Contact Us

Your Name (required)

Your Email (required)


Your Message

cold chain logistics

Forecasting The Future

Leadership involves managing current business challenges in a way that promotes future growth. For example, the pharmaceutical industry is under pressure to reduce drug prices.  Manufacturers are looking to increase efficiencies in their supply chain to maintain profits. This directly affects WDSrx relationships with manufacturers of prescription and over-the-counter medications. In order to continue to provide excellent service, several areas of our business are undergoing a change in order to...

WDSrx Shares Logistics Industry Intelligence Affecting Palm Beach County

Green Logistics Sustainability and conservation were the themes of the Logistics and Distribution Industry Task Force meeting organized by the Business Development Board of Palm Beach County. Task force members include supply chain professionals from leading companies in various industries operating from Palm Beach County.  The mission of the group is to update the Business Development Board about logistics issues as it recruits new companies to and supports expansion of companies currently loc...

WDSrx Promotes 3PL Benefits To Veterinary Brands at NASC Annual Conference

  At the National Animal Supplement Council annual conference in Doral, Florida, manufacturers of veterinary products gathered to learn and share information about innovations and developments within the animal health industry. WDSrx was asked to make a presentation to the over 300 guests in attendance about the relationship between pharmaceutical logistics and animal health products. Sam Seelenfreund, WDSrx Business Development Manager and Marketing Director Larry Hotz engaged the audience...

Cold Comfort – In Short Supply, WDSrx Partners With Pharmaceutical Client To Create Cold-Chain Capacity

Introduction Companies manufacturing pharmaceutical products requiring cold-chain storage at refrigerated or frozen temperatures are facing a scarcity of regulatory-compliant capacity meeting industry standards. The global market for cold chain medications was estimated at $318 billion in 20181 and is expected to rise approximately eight percent annually through 2022. However, the increase in supply for storage, handling and transporting these specialized products is expected to be less than the...

Are any Controlled Substances (CII) included in your return? If so, please press "Yes" and complete the DEA 222 Request Form. You can also contact Jason Solomon at or (561) 998-3885 x316.